Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
We explain how crypto assets resemble tokens and coins, highlighting differences in functionality, value, and governance.
28,655 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Explore how Fluent's Q1 2026 earnings could shape its year ahead. This article breaks down revenue trends, margins, a...
A promised Europe adventure collapsed, leaving families with unrefunded costs. This guide explains restitution, red f...
Six non-AI chip makers could be poised to benefit from the AI boom, as demand broadens beyond headline AI chips. Here...
Federal investigators say Yale's medical school admissions favored certain groups over others, a finding that adds to...
When a star turns a festival stage into a PR moment, money follows — but so do lessons in budgeting and branding. Thi...
In several large markets, prices are softening while buyer interest remains steady. This article explains the forces ...
Real estate can grow wealth or burn it, depending on where you buy. Learn which markets pose the biggest risks, the s...
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
In 2026, SoFi's private student loans and refinancing options face a competitive market and shifting rates. This sofi...
Thinking beyond quick wins, this guide shows how to build a reliable, growing income stream over two decades. Meet th...
When signatures don’t match on election forms, the financial stakes rise quickly. This article explains the money sid...